Member Info for caesar

Cash reserves were in order of £3m in January so all is well. Concepta's clinical results were positive, but the Chinese are subsequently conducting their own, and their results are due now. Prepaid orders, hopefully this month.

Spindok. Not so. Spoke to CPT at last weekend's Investor Show. All now up and running. Delay occasioned by having to retool the plastic monitorIng strip for the Chinese. One of their clinics are conducting their own test to verify Concepta's claims. Once confirmed, by even only one clinic, then the rest of the country will signal prepaid orders. By now it is imminent. EXCITING !!!

Spindok. Not so. Spoke to CPTs very confident management at the conference. All up and running. Retooled the plastic monitor for the Chinese. They subsequently needed to run their own tests to confirm CPTs claims. All going well. Only one, single, Chinese clinic needs to give the all clear then prepaid orders are placed throughout the country. By now, imminent. EXCITING !!!

Reynolds said there are no hospital testing delays and revenues expected mid to late March

Well, Reynolds promised first revenues by mid March, as Doncaster's 8 personnel are up and running. By now, the RNS is indeed imminent.

Gosh, now 18.5 to buy

A reminder. Broker view of potential markets: UK and Europe £350m, China £250m, and total global $2 billion. Beaufort's target sp 26p. First shipments could be early March

Reynolds stated in mid Dec to Winnifrith that there were no delays and that all was in order with the hospital tests. He emphasised that in China they have very advanced medical care and there are, indeed, lots of hospitals.

Going live: First product sales with upfront payment with orders should be early February. Lots of hospitals with positive feedback. £3m in bank. By now we are set to go.

The delay is obviously for a reason. Chinese are spending half a trillion $ buying up good companies in the West which augers well with their 5 year plan; they certainly know about Concepta..............

http://www.dailymail.co.uk/femail/article-3976278/BBC-Panorama-investigation-finds-lack-evidence-support-effectiveness-pricey-add-fertility-treatments.html

http://www.dailymail.co.uk/news/article-3972968/The-great-IVF-swindle-Couples-desperate-baby-sold-treatments-not-need-8-000.html

The trials were finalised at the end of September. One can now conclude that if there were small orders then they would have been placed by now. The fact that weeks have drifted by suggests that rather larger orders are being negotiated (quantity discounts etc). All rather encouraging.

and no similar competition.

If we equate the above, and OPTI are two years ahead, then by now the OPTI mkt cap would be about £634m (£29m now) giving an SP of just under £10 (40p now).

By now, OPTI are only capitalised at £29m and are two years ahead of 4D. We wonder if Mr.Woodford knows this ?

Tate and Lyle, has, I should imagine, already been alerted to the non-digestible sugar which Optibiotic are developing - in reality, they would be ideally suited to hire the technology or, perhaps, ponder a takeover - their market capitalisation is nearing £3 billion - so, indeed, by now , we have a scenario to consider .......

this company is developing a non-digestible sugar for the food industry - unimaginable possibilities - 1 in 3 will soon develop diabetes 2 - every food manufacturer is looking to find the 'holy grail' and it would appear that this is the nascent saviour

Tom Winnifrith, today, reiterates on shareprophets.com: 'I largely concur with these sentiments and we remain well ahead of the 4p offer price at which I tipped them on the Nifty Fifty in November 2012. From here I continue to consider fairer value to be 12p+. This continues to look a rare attractive tech play. Buy.' Well, by now, with a strong order back-log in excess of £7m, imminent results should please.

Not at all - in Hanke's presentation at UK Investor show last week in London, he reiterated that results will be confidently in line with expectations - he gave a very strong talk with enthusiasm. Winning business now from richer peers that cannot tender our full package. These peers have deep pockets with millions. So one can speculate on 1Spatial as a potential takeover target.